FDA-cleared pain devices

ActiPatch® product line

Electrome distributes ActiPatch®, an FDA 510(k) cleared PSWT device manufactured by BioElectronics Corporation and supported by published clinical evidence.

ActiPatch drug-free wearable device

Standard loop: 12 cm (4.7 inches) in diameter.

ActiPatch®: FDA 510(k) cleared (K192234), drug-free wearable for over-the-counter adjunctive treatment of musculoskeletal pain. From $39.99.

Buy ActiPatch® at actipatch.com
FDA 510(k) cleared

ActiPatch®

ActiPatch® is a wearable, drug-free, over-the-counter (OTC) medical device, FDA cleared (510(k) K192234) for over-the-counter adjunctive treatment of musculoskeletal pain. It is a form of bioelectric therapy, also called frequency medicine, and delivers 27.12 MHz pulsed shortwave therapy. Each device provides 720 therapy hours.

  • adjunctive treatment of musculoskeletal pain
Drug-freeNonthermalUp to 720 hours
Buy ActiPatch® at actipatch.com

Programs by Electrome

Two programs built around FDA cleared ActiPatch®. Both are in pre-release.

Pre-release

PREVENT™ by Electrome

A workplace program for employers and their employees: a short assessment, practical ergonomics and movement guidance, and optional ActiPatch® for current musculoskeletal pain.

See PREVENT™
Pre-release

PlayOn™ by Electrome

A program for athletes and the trainers who coach them: a sport-specific check, illustrated movements, and a pain log, with optional ActiPatch® for current musculoskeletal pain.

See PlayOn™

From 1 February 2027, FDA cleared ActiPatch® will be sold as FDA cleared LOOP™ by Electrome. The device and its FDA clearance stay the same.

ActiPatch® is an FDA 510(k) cleared PSWT device manufactured by BioElectronics Corporation and distributed by Electrome Corporation. It is indicated for adjunctive treatment of musculoskeletal pain and is not a substitute for medical care. It does not replace opioids or other prescribed treatments. Always consult your healthcare provider before starting any new therapy.

Appearance